GE HealthCare

Health Care Health Care Equipment Chicago, Illinois Last filing Feb 4, 2026 · FY2025

                    Revenue
                    FY2025
                
$20.6B
                    3y CAGR +4.0%
                    
                    P44
                    
                    n/a
                    
                    Net income
                    FY2025
                
$2.1B
                    Net margin +10.1%
                    
                    P48
                    
                    n/a
                    
                    Total assets
                    FY2025
                
$36.9B
                    ROA +5.6%
                    
                    P48
                    
                    n/a
                    
                    Operating cash flow
                    FY2025
                
$-1.0B
                    
                    n/a

5 yrs · FY2021–FY2025 9 filed · 0 derived · 0 blank

1Y 3Y 5Y

Dollars % of revenue % of assets YoY % CAGR

Each cell as a share of that year’s revenue.

Balance Sheet

Assets, liabilities, and equity

36 accounts · 1 year

Total assets $36.9B

Total liabilities $26.3B

Shareholders equity $10.4B

Account	2025	Trend
Assets
Cash and Cash Equivalents	21.8%
Short Term Investments	1.7%
Accounts Receivable	18.0%
Inventory	10.8%
Prepaid Expenses	3.5%
Other Current Assets	3.5%
Total Current Assets	60.6%
Property,Plant and Equipment	42.6%
Operating Lease Assets	2.0%
Goodwill	65.4%
Intangible Assets	5.5%
Long Term Investments	1.7%
Deferred Tax Assets	21.8%
Other Noncurrent Assets	10.7%
Total Assets	178.9%
Liabilities
Accounts Payable	15.8%
Accrued Liabilities	1.7%
Deferred Revenue	10.2%
Current Portion of Long Term Debt	2.4%
Operating Lease Liabilities	0.6%
Other Current Liabilities	7.7%
Total Current Liabilities	44.1%
Long Term Debt	46.0%
Deferred Revenue Noncurrent	3.9%
Operating Lease Liabilities Noncurrent	1.4%
Deferred Tax Liabilities	0.9%
Other Noncurrent Liabilities	10.0%
Total Liabilities	127.5%
Equity
Common Stock	0.0%
Additional Paid In Capital	32.5%
Retained Earnings	25.6%
Treasury Stock	1.1%
Accumulated Other Comprehensive Income	-6.7%
Noncontrolling Interest	0.1%
Total Stockholders Equity	50.3%
Total Liabilitiesand Equity	178.9%

Income Statement

Revenue, expense, and profitability

20 accounts · 1 year

Revenue $20.6B

Operating income $2.8B

Net income $2.1B

Account	2025	Trend
IncomeStatement
Revenues Total Revenue	100.0%
Expenses Research and Development	6.1%
Expenses Selling,General and Administrative	20.5%
Expenses Depreciation and Amortization	1.4%
Expenses Share Based Compensation	0.6%
Expenses Restructuring and Asset Impairment	0.5%
Expenses Operating Expenses	26.6%
Other Income Expense Gross Profit	40.0%
Other Income Expense Operating Income	13.4%
Other Income Expense Interest Income	0.2%
Other Income Expense Interest Expense	2.1%
Other Income Expense Other Income/expense	0.8%
Other Income Expense Income Before Tax	13.4%
Income Tax Income Tax Expense	3.0%
net Income net Income	10.1%
net Income Comprehensive Income	10.1%
Earnings Per Share Basic Eps	0.0%
Earnings Per Share Diluted Eps	0.0%
Earnings Per Share Weighted Average Shares Basic	2.2%
Earnings Per Share Weighted Average Shares Diluted	2.2%

Cash Flow Statement

Operating, investing, and financing flows

21 accounts · 1 year

Operating cash flow $-1.0B

Investing cash flow $-1.0B

Financing cash flow $617.0M

Account	2025	Trend
CashFlow
Operating Activities net Income	10.1%
Operating Activities Depreciation and Amortization	1.4%
Operating Activities Stock Based Compensation	0.6%
Operating Activities Deferred Income Taxes	0.6%
Operating Activities Changes In Operating Assets and Liabilities	1.5%
Operating Activities Other Non Cash Items	-1.0%
Operating Activities net Cash From Operating Activities	-5.1%
Investing Activities Business Acquisitions	1.8%
Investing Activities Purchases of Investments	0.6%
Investing Activities Other Investing Activities	0.3%
Investing Activities net Cash From Investing Activities	-5.1%
Financing Activities Repurchase of Common Stock	1.0%
Financing Activities Dividends Paid	0.3%
Financing Activities Proceeds From Stock Issuance	0.2%
Financing Activities Tax Withholding On Stock Based Compensation	0.2%
Financing Activities Other Financing Activities	-0.4%
Financing Activities net Cash From Financing Activities	3.0%
Cash Reconciliation Effect of Exchange Rate On Cash	0.3%
Cash Reconciliation net Change In Cash	7.9%
Cash Reconciliation Cash At Beginning of Period	21.9%
Cash Reconciliation Cash At End of Period	21.9%

Key Ratios

Margins, returns, liquidity, leverage, efficiency

Computed at import · 1 year

Ratio	2025
Profitability
Gross margin	—
Operating margin	+13.4%
Net margin	+10.1%
FCF margin	—
Growth
Revenue CAGR (3y)	+4.0%
Returns
ROE	+20.1%
ROA	+5.6%
ROIC	+13.5%
Liquidity
Current ratio	1.37x
Quick ratio	0.90x
Leverage
D/E	2.53x
Interest coverage	6.28x
Efficiency
Asset turnover	0.56x
Cash conversion cycle	—

Valuation

Price against fundamentals

FY2025 fundamentals · no price

No price data cached, so there is nothing to multiply. Load prices from the Stock Data tab and this panel reprices itself.

Notes

Your annotations

Not watched

GE HealthCare

Assets, liabilities, and equity

Revenue, expense, and profitability

Operating, investing, and financing flows

Margins, returns, liquidity, leverage, efficiency

Price against fundamentals

Your annotations

One-year price and volume history

Price data unavailable

Assets, liabilities, and equity

Revenue, expense, and profitability

Operating, investing, and financing flows

Margins, returns, liquidity, leverage, efficiency

Price against fundamentals

Your annotations

One-year price and volume history

Price data unavailable

Recent price history